SEO URLwww.firestrike.ai/deals/inozyme-pharma-biomarin-acquisition-2026
acquisitionAnnounced · Feb 8, 2026biotechnologySource · CredibleArticle · Expectations
BioMarin acquires Inozyme Pharma
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$270M
Target
Inozyme Pharma
US45790W1080 · Boston, Massachusetts
Acquirer
BioMarin
Full Acquisition
Status
Completed
BioMarin agreed to acquire Inozyme Pharma. Reported deal value: $270M. Status: Completed. Sector: biotechnology. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-08. Figures and status may change as filings and press coverage update.
Ad Inozyme Pharma Inc Stock: Buy or Sell?! New Inozyme Pharma Inc Analysis from February 8 delivers the answer
Deal timeline
Announced
Feb 8, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology with a reported deal value of $270M. Figures and status may change as sources update.
Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index